BA-3011

BA-3011 Catalog number: BADC-00030

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

BA-3011 is a novel conditionally active biologic AXL-targeted antibody-drug conjugate used to treat solid tumor. The CAB technology is aimed to improve the selectivity of BA-3011 for binding to AXL receptor on cancer cells.

General Information

Category
ADCs Cytotoxin with Linkers
Product Name
BA-3011
Catalog Number
BADC-00030
Application
the treatment of solid tumor
Current Developer
BioAtla

Related Products

Get in Touch

Verification code
Inquiry Basket